Investor Relations

CEVEC Pharmaceuticals GmbH has recently completed a new financing round adding the highly-reputed investors Creathor Venture, D-Bad Homburg, NRW.Bank and the development bank of the state of North-Rhine Westphalia to its investor panel. The previous institutional investors Sparkasse KölnBonn and KfW, as well as the major private investors and CEVEC’s management took part in the new capital round.
CEVEC’s staff enjoys a participation in the overall company success via an own investment vehicle (Mitarbeiter GbR) eligible for all employees thus striving to maximize motivation.

Creathor Venture invests in technology-oriented companies and entrepreneurs in the areas of life science, IT, telecommunication, new media, new materials, electronics, nanotechnology and clean technologies. Creathor Venture’s management team includes Dr. Gert Köhler, the founder of the former Technologieholding VC GmbH, as well as Ingo Franz and Karlheinz Schmelig. The team has been working in early-stage venture capital for 20 years. During that time more than 200 technology companies have been financed and over 20 IPOs as well as numerous trade sales have been conducted. Successful portfolio companies in the field of life sciences are Accovion, SiRION Biotech, Caprotec Bioanalytics, PhenexPharmaceuticals and CEVEC Pharmaceuticals.

NRW.BANK is the development bank of the State of North Rhine-Westphalia. Its four business segments are promotion of business start-ups and SME’s, municipal and infrastructure financing, social housing promotion and individual promotion. For business start-ups and SMEs in North Rhine-Westphalia, NRW.BANK uses customized public promotion and equity finance products and, among others, actively invests in technology and life science ventures. The bank aims to constantly improve the financing situation of this target group in line with actual requirements.

Sparkasse KölnBonn is the largest communal savings bank under public law in Germany. Besides a full range of banking services to retail and corporate
customers the bank also offers equity solutions. The venture capital investments of Sparkasse KölnBonn have always been realized together with other investors well versed in the particular industry and are concentrated on the area around the two cities Cologne and Bonn.

KfW Mittelstandsbank offers solutions for business start-ups and small and medium-sized enterprises, thus promoting commercial investments over the entire life cycle of an enterprise. All financing products are structured according to the three pillars of loan, mezzanine and equity capital.

GAT Holding (Switzerland) and other private investors are complementing the investor panel of CEVEC Pharmaceuticals GmbH.